BIOLIT ApS: Financial statements 2019
CVR: 10068460
Source: annual report 2019, Danish Business Authority
01/06/2018 – 31/05/2019
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,966,357 and a net result of DKK 1,475,787 compared with DKK 953,640 the year before. That is an increase of 56.6% compared with the year before. Equity in the 2019 report amounted to DKK 7,081,909. The solvency ratio was 59.8%.
- Gross Profit
- DKK 1,966,357
- Profit/Loss
- DKK 1,475,787
- Equity
- DKK 7,081,909
- Total Assets
- DKK 11,851,649
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2 mio. | 1.5 mio. | 7.1 mio. | - |
| 2018 | - | 1.3 mio. | 954 t. | 5.6 mio. | - |
| 2017 | - | 1.4 mio. | 1.1 mio. | 4.7 mio. | - |
| 2016 | - | 1.8 mio. | 1.4 mio. | 3.6 mio. | - |
| 2015 | - | 1.1 mio. | 795 t. | 2.2 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees (2006). In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity in the 2025 report amounted to DKK 10,762,624.